ScholarIQanswers from OpenAlex & ORCID
Lee S. Schwartzberg
ResearcherPublications, citations & collaboration network
Lee S. Schwartzberg is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Lee S. Schwartzberg have?
ScholarIQindexed works
Lee S. Schwartzberg has 686 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Lee S. Schwartzberg have?
ScholarIQcitation count
Lee S. Schwartzberg has 20,363 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Lee S. Schwartzberg?
ScholarIQh-index
Lee S. Schwartzberg has an h-index of 63 in OpenAlex.
What is the i10-index of Lee S. Schwartzberg?
ScholarIQi10-index
Lee S. Schwartzberg has an i10-index of 250 in OpenAlex.
What is the ORCID of Lee S. Schwartzberg?
ScholarIQorcid
The ORCID for Lee S. Schwartzberg is on the source record.
What is the OpenAlex record for Lee S. Schwartzberg?
ScholarIQopenalex
The OpenAlex for Lee S. Schwartzberg is on the source record.
What are the most-cited papers on Lee S. Schwartzberg?
ScholarIQmost cited works
2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice Guideline
Thomas J. Smith, James Khatcheressian, Gary H. Lyman, Howard Ozer, Jamés O. Armitage, Lodovico Balducci, Charles L. Bennett, Scott B. Cantor, Jeffrey Crawford, Scott J. Cross, George D. Demetri, Christopher E. Desch, Philip A. Pizzo, Charles A. Schiffer, Lee S. Schwartzberg, Mark R. Somerfield, George Somlo, James C. Wade, James L. Wade, Rodger J. Winn, Antoinette J. Wozniak, Antonio C. Wolff
A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy
Matti Aapro, H. S. Rugo, Antônio Rossi, Giada Rizzi, Maria Elisa Borroni, Igor Bondarenko, Tomasz Sarosiek, Cristina Oprean, Servando Cardona‐Huerta, Vito Lorusso, M. Karthaus, Lee S. Schwartzberg, Steven M. Grunberg
Safety, Efficacy, and Patient-Reported Health-Related Quality of Life and Symptom Burden with Nivolumab in Patients with Advanced Non–Small Cell Lung Cancer, Including Patients Aged 70 Years or Older or with Poor Performance Status (CheckMate 153)
David R. Spigel, Michael McCleod, Robert M. Jotte, Lawrence H. Einhorn, Leora Horn, David Waterhouse, Ben Creelan, Sunil Babu, Natasha B. Leighl, Jason C. Chandler, Félix Couture, George P. Keogh, Glenwood Goss, Davey B. Daniel, Edward B. Garon, Lee S. Schwartzberg, Rohini Sen, Beata Korytowsky, Ang Li, Nivedita Aanur, Maen Hussein